Urologie Update

"Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology”, NatureCancer 2025

Aktuelle Programme zur molekularen Diagnostik

Korrektes Management von Paravasaten

Zhao et al; “In vitro and in vivo study of antibacterial and anti-encrustation coating on ureteric stents”, BJU

Kinnaird et al;  “Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis: The OPTIMUM randomized clinical trial, JAMA 2025 

Management von Koageltamponaden der Harnblase

Del Muro et al.; “Retifanlimab in advanced penile squamous cell carcinoma: The Phase 2 ORPHEUS Study, Eur Urol Onc 2025

Soderberg et al.; “Percutaneous nephrolithotomy vs retrograde intrarenal surgery for renal stones: a Cochrane Review, BJUOI 2024

DeLong et al.; "Long-Term outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: Five-Year Results From the ROBUST I Study", JU 2025

Eraky et al; “Bladder neck involvement in non-muscle-invasive bladder cancer: risk implications and outcomes of BCG vs Gemcitabine/Docetaxel”, BJUI 2025

Song et al; “Stereotactic Body Radiation Therapy for primary renal cancer and genetic markers of response: A Phase 2 Trial”, EUO 2025

Wang et al; “Real-World Experience with a commercial circulating tumor DNA assay in non-muscle-invasive bladder Cancer

Connor et al; “Combination cytoreductive surgery, radiotherapy, or ablation for de novo metastatic prostate cancer: The IP2-ATLANTA Internal Pilot, Phase 2, randomised controlled Trial”, EUO